NCOR1 and prostate cancer: Analysis of CK2-specific NCoR phosphorylation in prostate cancer patients revealed that 89% of samples (55 tissues) show positive staining for NCoR Ser (P)-2436, with 31% demonstrating a high score (≥5) for NCoR phosphorylation, 68.8% showing a high Gleason score (≥8), and 15.4% displaying a low Gleason score (≤7; Fig. 5B).